Corporate News

Gerresheimer Annual Report honoured four times in New York

  • ARC Award (Annual Report Competition) in Gold for Interior Design and Photography  
  • Silver Award for Cover Photo and Honors Award for Financial Data  
  • ”The award highlights the importance which Gerresheimer attaches to communication with the capital market and the public,” says Dr. Axel Herberg, Chief Executive Officer of Gerresheimer AG.  

The annual report of Gerresheimer AG has been honoured in the ARC Awards in New York by two Gold Awards, one Silver Award and an Honors Award. A total of 2,100 annual reports from 28 countries were submitted for the contest. The ARC Awards have been sponsored annually since 1989 by MerComm, Inc./The International Academy of Arts & Sciences and are distributed at a gala event in New York.

Gold was won by Gerresheimer in the category of ”Interior Design? as well as the category of ”Photography?. For ”Cover Photo/Design” it carried off a Silver Award. Finally the annual report won an Honors Award in the category of ”Financial Data?.

”Communication with the capital market, our shareholders, customers and the public is a top priority for Gerresheimer. The awards for our 2007 annual report are an incentive for us to continue to provide transparent and comprehensive information about our company in the future,? says Dr. Axel Herberg, CEO of Gerresheimer AG.

The prizes were awarded in New York on September 18, 2008. In Germany, the prize-winning annual reports can be seen from September 26 to October 19, 2008 at the Gallery of Contemporary Art in the Museum für Kunst und Gewerbe in Hamburg. The exhibition is organised under the patronage of Hamburg Finance Senator Dr. Michael Freytag.

About Gerresheimer

Gerresheimer employs more than 10,000 people in 40 locations in Europe, America and Asia. In the financial year 2007, worldwide sales totalled €958m. The product portfolio ranges from pharmaceutical vials made of glass and plastic through to complex drug-delivery systems for the pharma & life science industry. These include sterile syringes, inhalers and other system-based approaches for safe dosage and application of medications. The Group enjoys a leading position in markets which are characterised by high technical and regulatory barriers.

P.S.: You can download the Annual Report 2007 on our website.
Click here.

Anke Linnartz
Director Corporate Investor Relations
Telephone  +49 211 6181 314
Telefax +49 211 6181 121
E-Mail: please click

Contact us!
Communication & Marketing
+49 211 61 81 251